Resumen
Introduction: Patients admitted to the critical care unit are subject to constant monitoring to optimize their medical management and offer the best possible prognosis. Within the monitoring strategies, glycemic control highly studied since glycemic variability is considered a significant risk factor for morbidity and mortality in these patients. Objective: Correlate capillary glucose variability with in-hospital morbidity and mortality of patients in the critical care unit. General Hospital for Diseases of the Guatemalan Social Security Institute. Methodology: A descriptive and analytical prospective study was carried out and a correlation analysis was carried out. A total of 290 patients admitted to the intensive care unit of the IGSS were included. Capillary glucose tests were performed to later determine the capillary glucose variability using the standard deviation, this was correlated with morbidity and mortality. Results: Patients with a higher glucose standard deviation correlate with higher mortality (R=0.249, R2=0.06, p<0.001) and morbidity given by the SOFA scale (R=0.27, R2=0.07, p<0.001). Conclusion: The study showed that an increase in the variability of capillary glucose correlates with an increase in the morbidity and mortality of patients during their stay in the critical care area.
Citas
Adhikari, N., Fowler, R., Bhagwanjee, S., Rubenfeld, G. Critical care and the global burden of critical illness in adults. The Lancet. 2010, Oct.; 376(9749): 1339-1346. https://doi.org/10.1016/S0140-6736(10)60446-1
Cavalcanti, A.B., Bozza, F.A., Machado, F.R., Salluh, J., Pelisser Campagnucci, V., Vendramim, P., Guimaraes, H.P., Normilio-Silva, K., Petri Damiani, L., Romano, E., Carrara, F., Lubarino Diniz de Sousa, J., Reis Silva, A., Ramos, G. V., Teixeira, C., Da silva, N.B., Chang-Chou, C.C., Angus, D.C., Berwanger, O. Effect of a quality improvement intervention with daily round checklists, goal setting, and clinician prompting on mortality of critically ill patients: a randomized clinical trial. JAMA. 2016, April; 315(2): 1480-1490. https://doi.org/10.1001/jama.2016.3463
World Health Organization. Global Health Risks: mortality and burden of disease attributable to selected major risks. WHO, 2009; 62 p. https://apps.who.int/iris/handle/10665/44203
Finney, S.J., Zekveld, C., Elia, A., Evans, T.W. Glucose control and mortality in critically ill patients. JAMA. 2003, Oct.; 290(15): 2041-2047. https://doi.org/10.1001/jama.290.15.2041
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001, Dec.; 414(6865): 813–820. https://doi.org/10.1038/414813a
Brownlee, M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005, June.; 54(6): 1615–1625. https://doi.org/10.2337/diabetes.54.6.1615
Brownlee, M., Hirsch, I.B. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA. 2006, April; 295(14): 1707–1708. https://doi.org/10.1001/jama.295.14.1707
Chao, H.Y., Liu, P.-H., Lin, S.C., Chen, C.K., Chen, J.C., Chan, Y.L., Wu, C.C., Blaney, G.N., Liu, Z.Y., Wu, C.J., Chen, K.-F. Association of In-Hospital Mortality and Dysglycemia in Septic Patients. PLOS One. 2017, January; 12, e0170408. https://doi.org/10.1371/journal.pone.0170408
Wiener RS, Wiener DC, Larson RJ. (2008) Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008, Aug.; 300(8): 933–944. https://doi.org/10.1001/jama.300.8.933
Griesdale, D.E., de Souza, R.J., van Dam, R.M., Heyland, D.K., Cook, D.J., Malhotra, A., Dhaliwal, R., Henderson, W.R., Chittock, D.R., Finfer, S., Talmor, D. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. Canadian Medical Association Journal. 2009, April; 180(8): 821-827. https://doi.org/10.1503/cmaj.090206
DeVries, J.H. Glucose Variabilty: Where it is Important and How to Measure It. Diabetes. 2013, May; 62(5): 1405-1408. https://doi.org/10.2337/db12-1610
Krinsley, J.S., Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2017, Oct.; 35(10): 2262-2267. https://doi.org/10.1097/01.CCM.0000282073.98414.4B
Bagshaw, S.M., Bellomo, R., Jacka, M.J., Egi, M., Hart, G.K. George, C., The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care. 2009, June; 13(3): R91 https://doi.org/10.1186/cc7921
Jay, D., Hitomi, H., Griendling, K.K.. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med. 2006, Jan.; 40(2): 183–192. https://doi.org/10.1016/j.freeradbiomed.2005.06.018
Piconi, L., Quagliaro, L., Assaloni, R., Da Ros, R., Maier, A., Zuodar, G., Ceriello, A. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab Res Rev. 2006, May-June; 22(3): 198 –203. https://doi.org/10.1002/dmrr.613
Takeuchi, A., Throckmorton, D.C., Brogden, A.P., Yoshizawa, N., Rasmussen, H., Kashgarian, M. Periodic high extracellular glucose enhances production of collagens III and IV by mesangial cells. Am J Physiol. 1995, Jan.; 268(1 Pt 2): F13-9. https://doi.org/10.1152/ajprenal.1995.268.1.F13
Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J.P., Colette, C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006, April; 295(14): 1681-1687. https://doi.org/10.1001/jama.295.14.1681
Kilpatrick, E.S., Rigby, A.S., Atkin, S.L. Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control. Clin Chem. 2007, May; 53(5): 897-901. https://doi.org/10.1373/clinchem.2006.079756
Siegelaar, S.E., Holleman, F., Hoekstra, J.B.L., & DeVries, J.H. Glucose Variability: Does it matter? Endocrine Reviews. 2010, April; 31(2): 171-182. https://doi.org/10.1210/er.2009-0021
Eslami, S., Taherzadeh, Z., Schultz, M., & Abu-Hanna, A. Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Medicine. 2011, April; 37(4): 583-593. https://doi.org/10.1007/s00134-010-2129-5
Todi, S., & Bhattacharya, M. Glycemic variability and outcome in critically ill. Indian Journal of Critical Care Medicine. 2014, May; 18(5): 285–290. https://doi.org/10.4103/0972-5229.132484
Vincent, J.L. Blood glucose control in 2010: 110 to 150 mg/dL and minimal variability. Critical Care Medicine. 2010, March; 38(3): 993–995. https://doi.org/10.1097/CCM.0b013e3181d16b2e
Ali, N.A., O’Brien, Jr., J.M., Dungan, K., Phillips, G., Marsh, C.B., Lemeshow, S., Connors, Jr., A.F., Preiser. J.C. Glucose variability and mortality in patients with sepsis. Critical Care Medicine. 2008, August; 36(8): 2316-2321. https://doi.org/10.1097/CCM.0b013e3181810378
Dossett LA, Cao H, Mowery NT, Dortch MJ, Morris JM Jr, May AK. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am., Surg. 2008, August; 74(8): 679-685; discussion 685. https://doi.org/10.1177/000313480807400802
Egi, M., Bellomo, R., Stachowski, E., French, C.J., Hart, G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology. 2006, August; 105(2): 244-252. https://doi.org/10.1097/00000542-200608000-00006
Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics; 2006, July; 118(1): 173-179. https://doi.org/10.1542/peds.2005-1819
Akirov, A., Diker-Cohen, T., Masri-Iraqi, H., & Shimon, I. High Glucose Variability Increases Mortality Risk in Hospitalized Patients. J. Clinical Endocrinology Metabolism. 2017, July; 102(7): 2230-2241. https://doi.org/10.1210/jc.2017-00450
Mendez, C.E., Mok, K.T., Ata, A., Tanenberg, R.J., Calles-Escandon, J., Umpierrez, G.E. Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. Diabetes Care; 2013, Dec.; 36(12): 4091–4097. https://doi.org/10.2337/dc12-2430
NICE-SUGAR Study Investigators, Finfer, S., Chittock, D.R., Intensive versus conventional glucose control in critically ill patients. N Engl J Me; 2009, March; 360(13): 1283-1297. https://doi.org/10.1056/NEJMoa0810625
Papachristoforou, E., Lambadiari, V., Maratou, E., Makrilakis, K. Association of Glycemic
Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications. J Diabetes Res; 2020; October; 7489795795. https://doi.org/10.1155/2020/7489795
Mendez, C.E., Mok, K.T., Ata, A., Tanenberg, R.J., Calles-Escandon,, J., Umpierrez, G.E. Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. Diabetes Care. 2013, December; 36(12): 4091–4097. https://doi.org/10.2337/dc12-2430
Hemanides, J., Vriesendrop, T.M., Bosman, R.J., Zandstra, D.F., Hoekstra, J.B., & DeVries, J.H. Glucose variability is associated with intensive care unit mortality. Critical Care Medicine. 2010, Mar; 38(3):838-842. https://doi.org/10.1097/CCM.0b013e3181cc4be9
Cook, D. J. Approach to the Patient in a Critical Care Setting. In L. Goldman, & A. Schafer, Goldman-Cecil Medicine. 26th ed. Part 10: Critical care medicine. Cecil. 2020;1(26). https://booksite.elsevier.com/samplechapters/9781437716047/Sample%20Chapters%20and%20Table%20of%20Contents.pdf
Copyright
License
Copyright (c) 2022 Alejandro Bautista Hurtarte, Sergy Melissa Campos Martínez y Jorge Luis Ranero Meneses
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish in this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License 4.0 (CC BY-NC_SA 4.0) that indicates: a) It is allowed that others share the work, with an acknowledgement of the work's authorship and initial publication in this journal, b) The work may not be used for commercial purposes, c) If it's remixed, transformed, or built upon the material, one must distribute the contributions under the same license as the original
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository, website or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
